Xcout Intel
Healome competitors & alternatives
The 12 closest competitors and alternatives to Healome among biotech companies — ranked by similarity to what Healome actually does, not by market-cap band.
Subscribe to see Healome’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Healome
Healome Therapeutics Ltd is an eye care and ophthalmology therapeutics company founded in 2021 and headquartered in Birmingham, United Kingdom. The company develops safer and more effective ocular drug delivery treatments for vision-threatening ocular surface diseases.
Healome at a glance
Healome is a biotech company headquartered in United Kingdom. Its most recent funding round, Seed, raised $2.7M in July 2026. Xcout tracks 1 named person at Healome, including Richard Williams (Chief Executive).
Healome leadership
- Richard WilliamsChief Executive
Healome funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $2.7M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Healome competitors
Ranked by semantic similarity — how close each company is to Healome by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
MCAL Therapeutics Inc. is a biotechnology company developing synthetic, rabbit-inspired lipid eye drops and extended-release drug delivery platforms. Its lead candidate, MCAL-201, is designed to treat evaporative dry eye disease by restoring the tear film's protective lipid barrier.
Similar biotech company
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company based in Cambridge, Massachusetts, dedicated to developing treatments that preserve the sight of individuals impacted by severe eye diseases.
Biotechnology
Eyevensys is a biotechnology company developing non-viral gene therapies for ophthalmic diseases. Its platform uses electro-transfection of the eye’s ciliary muscle to enable sustained local production of therapeutic proteins for retinal and other ocular conditions.
Similar biotech company
Alterome Therapeutics, Inc. is a clinical-stage precision oncology company headquartered in San Diego, California, founded in 2021. The privately held biotech firm focuses on developing targeted therapies to address genomically defined cancer drivers and intractable oncological targets.
Biotechnology
Tarsier Pharma Ltd. is a late clinical-stage pharmaceutical company that develops bio-inspired medical solutions for autoimmune and inflammatory ocular diseases. The company utilizes a proprietary molecule-derived technology platform to target conditions such as non-infectious uveitis and uveitic glaucoma through eye drops and intravitreal injections.
Biotechnology
Aperta Biosciences is a biopharmaceutical company that develops novel therapeutics for ocular surface diseases, including blepharitis, ocular rosacea, meibomian gland dysfunction, and dry eye disease. The company's lead candidate, APT-001, is an ophthalmic suspension designed to treat the underlying cause of blepharitis by eradicating ocular Demodex infestations.
Biotechnology
Broadwing Bio is a biotechnology company that develops antibody-based therapies to treat major causes of adult vision loss, specifically focusing on Geographic Atrophy and Glaucoma. The company utilizes genetics-driven insights to target ocular diseases and preserve vision for patients.
Biotechnology
Graybug Vision, Inc. is a clinical-stage biopharmaceutical company headquartered in Redwood City, California, with additional offices in Baltimore, Maryland, focused on developing medicines for ocular diseases.
Similar biotech company
Zhaoke Ophthalmology Limited is an ophthalmic pharmaceutical company dedicated to researching, developing, and commercializing therapeutic solutions addressing significant unmet medical requirements in the People's Republic of China. The company is advancing a range of medications designed for various ocular conditions, impacting both the anterior and posterior segments of the eye, such as dry eye disease, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma. It was previously known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was established in 2017 and operates from its headquarters in Guangzhou, People's Republic of China.
Similar biotech company
Scarlet Therapeutics, founded in 2021 and headquartered in Bristol, United Kingdom, is developing a pioneering platform that generates novel red blood cell-based therapeutics to treat a wide range of diseases.
Similar biotech company
Healios K.K., a Tokyo-based biopharmaceutical firm established in 2011, specializes in the discovery, development, manufacturing, and commercialization of advanced cell and regenerative medical therapies. The company operates across key markets including Japan, Europe, and the United States. Its robust pipeline features several cellular and tissue-based products, such as HLCR011 and HLCR012, which are induced pluripotent stem cell (iPSC)-derived regenerative medicines aimed at treating age-related macular degeneration. Another iPSC-based therapy, HLCL041, is being developed for metabolic liver disease. Furthermore, Healios is progressing HLCM051, a regenerative treatment designed for ischemic stroke and acute respiratory distress syndrome, alongside HLCN061 for solid tumor indications. The company also maintains a joint research partnership with Hyogo Medical University, focusing on eNK cell-based cancer immunotherapies to combat mesothelioma. Healios K.K. adopted its current name in September 2013, having previously operated under the name Retina Institute Japan, K.K.
Biotechnology
Memento Medicines, Inc. is a privately held biotechnology company headquartered in Boston, Massachusetts, focused on developing novel biologic therapies for retinal diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Healome and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Healomeand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →